Practice Areas -

Corporate and M&A Law Firms and Lawyers

  • Search Result as
  • By Days
  • Between Dates

Practice Areas - Corporate and M&A Law Firms and Lawyers

Deal Date: 09-07-2020 Practice Area: Corporate and M&A
Deal Title: JW Therapeutics Completion of Series B Round Financing Industry: Pharmaceuticals & Biotechnology
JW Therapeutics announced the completion of a USD100 million Series B round financing. The investment was co-led by CPE and Mirae Asset, jointed by CR-CP Life Science Fund and Oriza Holdings, as well as existing investors including Loyal Valley Capital, Temasek, Sequoia Capital China, ARCH Venture Partners, Juno Therapeutics, a Bristol Myers Squibb company, and WuXi AppTec. This round of financing brought the total capital raised to over USD200 million. Latham and Watkins LLP represented Juno Therapeutics in the transaction.
Financial Center: Silicon Valley Value: 0.00-100.00
Advised Party: Venture/Growth Investor Law Firm
Investee 1 Jurisdiction United States Investee 2 Jurisdiction United States
Classification: Venture and Growth Capital Healthcare
Lawyer Judith A Hasko